Published July 2019 | Version v1
Journal article

Locoregional Control and Mild Late Toxicity After Reducing Target Volumes and Radiation Doses in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Treated With Induction Chemotherapy (IC) Followed by Concurrent Chemoradiotherapy: 10-Year Results of a Phase 2 Study

  • 1. State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, P.R. (China)
  • 2. Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Wuhan University, Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, P.R. (China)

Description

To evaluate the long-term locoregional control, failure patterns, and late toxicity after reducing the target volume and radiation dose in patients with locoregionally advanced nasopharyngeal carcinoma patients treated with induction chemotherapy (IC) plus concurrent chemoradiotherapy (CCRT).

Additional details

Identifiers

DOI
10.1016/j.ijrobp.2019.03.043;
PII
S036030161930570X;

Publishing Information

Journal Title
International Journal of Radiation Oncology, Biology and Physics
Journal Volume
104
Journal Issue
4
Journal Page Range
p. 836-844
ISSN
0360-3016
CODEN
IOBPD3

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
55057177
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
CARCINOMAS; CHEMOTHERAPY; COMBINED THERAPY; FAILURES; PATIENTS; RADIATION DOSES; TOXICITY
Descriptors DEC
DISEASES; DOSES; MEDICINE; NEOPLASMS; THERAPY

Optional Information

Copyright
Copyright (c) 2019 Elsevier Inc. All rights reserved.